Cardiff Oncology, Inc. (CRDF) › EPS (Diluted)Cardiff Oncology, Inc. (CRDF) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2012: $-0.892013: $-0.702014: $-0.882015: $-1.212016: $-1.372017: $-51.762018: $-8.262020: $-1.082021: $-0.732022: $-0.892023: $-0.932024: $-0.952025: $-0.69$-0.692012EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.69+27.4%2024$-0.95-2.2%2023$-0.93-4.5%2022$-0.89-21.9%2021$-0.73+32.4%2020$-1.08—2018$-8.26+84.0%2017$-51.76-3678.1%2016$-1.37-13.2%2015$-1.21-37.5%2014$-0.88-25.7%2013$-0.70+21.3%2012$-0.89—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share